tiprankstipranks
Tiziana Life Sciences (US) (TLSA)
NASDAQ:TLSA
US Market
TLSA
Tiziana Life Sciences
RESEARCH TOOLSreports

Tiziana Life Sciences (TLSA) Stock News & Sentiment

681 Followers
Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
Premium
Company Announcements
Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
5d ago
6K
TLSA
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS
Premium
Company Announcements
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS
1M ago
6K
TLSA
Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal
Premium
Company Announcements
Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal
3M ago
6K
TLSA
Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials
Premium
Company Announcements
Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials
3M ago
6K
TLSA
Tiziana Life Sciences Raises Up to $17.6 Million in Insider-Led Direct Offering to Fund Phase 2 Trials
Premium
Company Announcements
Tiziana Life Sciences Raises Up to $17.6 Million in Insider-Led Direct Offering to Fund Phase 2 Trials
3M ago
6K
TLSA
Tiziana Life Sciences to Showcase Intranasal Foralumab at Neuroscience Innovation Forum During JPM Week
Premium
Company Announcements
Tiziana Life Sciences to Showcase Intranasal Foralumab at Neuroscience Innovation Forum During JPM Week
3M ago
6K
TLSA
Tiziana Reports Clean FDA Safety Update for Intranasal Foralumab After 37.4 Patient-Years of Exposure
Premium
Company Announcements
Tiziana Reports Clean FDA Safety Update for Intranasal Foralumab After 37.4 Patient-Years of Exposure
3M ago
6K
TLSA
More TLSA News >

TLSA News on the Web

Tiziana Life Sciences reports positive preclinical findings for intranasal anti-CD3 therapy in brain
Proactive Investors
Bullish
Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
TipRanks News
Bullish
Tiziana reports biomarker gains for nasal MS therapy in progressive disease
Proactive Investors
Bullish
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS
TipRanks News
Bullish
Tiziana Life Sciences announces new data on nasal foralumab
TipRanks News
Bullish
Tiziana Life Sciences publishes positive study on intranasal MS therapy
Proactive Investors
Bullish
Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials
TipRanks News
Bullish
Tiziana Life Sciences announces closing of oversubscribed $8.8M offering
Proactive Investors
Bullish

News Score - Last 7 Days

Positive
TLSA
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TLSA’s Media Buzz Sentiment?
2 articles about TLSA were published this week. In an average week, 1 articles are published.
    What is TLSA’s weekly average amount of articles?
    In an average week, 1 articles about TLSA are published.
      What is TLSA’s News Sentiment?
      100% of articles about TLSA were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        OMEROmeros
        AGIOAgios Pharma
        2273Gushengtang Holdings Limited
        PALIPalisade Bio
        IVAInventiva
        Showing the stocks with the most bullish news sentiment over the past week